Brett Mitchell Selected Research

Cholangiocarcinoma

12/2008

The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brett Mitchell Research Topics

Disease

1	Bacteriuria 01/2021
1	Urinary Tract Infections (Urinary Tract Infection) 01/2021
1	Proteinuria 01/2010
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2010
1	Hypertension (High Blood Pressure) 01/2010
1	Pre-Eclampsia (Preeclampsia) 01/2010
1	Neoplasms (Cancer) 12/2008
1	Cholangiocarcinoma 12/2008

Drug/Important Bio-Agent (IBA)

1	Local Anti-Infective Agents (Antiseptics)IBA 01/2021
1	ChlorhexidineIBA 01/2021
1	SteroidsIBA 01/2010
1	bufogeninIBA 01/2010
1	Adenosine Triphosphatases (ATPase)IBA 01/2010
1	marinobufageninIBA 01/2010
1	EndocannabinoidsIBA 12/2008
1	anandamide (arachidonylethanolamide)IBA 12/2008

Therapy/Procedure

1	Catheters 01/2021
1	Urinary Catheters 01/2021